A qualitative exploration of the experiences of adults with cystic fibrosis unable to benefit from triple combination therapy
Journal of Health Psychology: An Interdisciplinary, International Journal
Published online on October 02, 2025
Abstract
Journal of Health Psychology, Volume 31, Issue 6, Page 2455-2469, May 2026.
Elexacaftor/Tezacaftor/Ivacaftor (ETI) is a highly effective modulator therapy that has transformed the lives of many people with Cystic Fibrosis (CF). However, limited research has explored the experiences of those not able to benefit from ETI due to ...
Elexacaftor/Tezacaftor/Ivacaftor (ETI) is a highly effective modulator therapy that has transformed the lives of many people with Cystic Fibrosis (CF). However, limited research has explored the experiences of those not able to benefit from ETI due to ...